BCM
ANGO icon

Bridgeway Capital Management’s AngioDynamics ANGO Stock Holding History

Bridgeway Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-35,400
Closed -$324K – 1180
2024
Q4 		$324K Sell
35,400
-53,000
-60% -$390K 0.01% 906
2024
Q3 		$688K Hold
88,400
– – 0.01% 776
2024
Q2 		$535K Buy
+88,400
New +$545K 0.01% 843
2019
Q4 		– Sell
-132,300
Closed -$2.44M – 1309
2019
Q3 		$2.44M Hold
132,300
– – 0.03% 427
2019
Q2 		$2.6M Sell
132,300
-60,000
-31% -$1.22M 0.03% 430
2019
Q1 		$4.4M Hold
192,300
– – 0.05% 271
2018
Q4 		$3.87M Sell
192,300
-15,300
-7% -$317K 0.05% 260
2018
Q3 		$4.51M Hold
207,600
– – 0.04% 339
2018
Q2 		$4.62M Hold
207,600
– – 0.05% 334
2018
Q1 		$3.58M Buy
207,600
+69,500
+50% +$1.16M 0.04% 383
2017
Q4 		$2.3M Buy
138,100
+500
+0.4% +$8.53K 0.02% 550
2017
Q3 		$2.35M Buy
137,600
+7,900
+6% +$133K 0.03% 531
2017
Q2 		$2.1M Sell
129,700
-450
-0.3% -$7.11K 0.03% 566
2017
Q1 		$2.26M Buy
130,150
+63,300
+95% +$1.06M 0.03% 530
2016
Q4 		$1.13M Buy
66,850
+450
+0.7% +$7.5K 0.01% 771
2016
Q3 		$1.17M Hold
66,400
– – 0.02% 733
2016
Q2 		$954K Buy
66,400
+35,000
+111% +$437K 0.01% 803
2016
Q1 		$386K Buy
31,400
+14,400
+85% +$159K 0.01% 1139
2015
Q4 		$206K Buy
+17,000
New +$209K ﹤0.01% 1295
2015
Q3 		– Sell
-151,900
Closed -$2.49M – 1464
2015
Q2 		$2.49M Sell
151,900
-350
-0.2% -$5.81K 0.05% 438
2015
Q1 		$2.71M Buy
152,250
+350
+0.2% +$6.5K 0.06% 411
2014
Q4 		$2.89M Hold
151,900
– – 0.07% 380
2014
Q3 		$2.08M Hold
151,900
– – 0.05% 471
2014
Q2 		$2.48M Sell
151,900
-550
-0.4% -$7.96K 0.07% 445
2014
Q1 		$2.4M Buy
152,450
+550
+0.4% +$8.96K 0.07% 431
2013
Q4 		$2.61M Hold
151,900
– – 0.08% 365
2013
Q3 		$2M Buy
+151,900
New +$1.79M 0.07% 431

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgeway Capital Management's ANGO Position: Q1 2025 in Review

Bridgeway Capital Management sold out of AngioDynamics (ANGO) in Q1 2025, closing a stake of 35,400 shares — an estimated $324K sold.

Bridgeway Capital Management first reported a position in ANGO in Q3 2013 and held it in 27 quarters. The position peaked at $4.62M in Q2 2018. 154 funds tracked by Wall St. Rank hold ANGO as of Q1 2025.

  • Bridgeway Capital Management reported no remaining AngioDynamics position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 35,400 AngioDynamics shares in Q1 2025, an estimated $324K.
  • Bridgeway Capital Management first reported a position in AngioDynamics in Q3 2013 and held it in 27 quarters.
  • Bridgeway Capital Management's AngioDynamics position peaked at $4.62M in Q2 2018.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.